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1. INTRODUCTION {#cas14511-sec-0001}
===============

Esophageal cancer is one of the common digestive tract malignant tumors, which has severely threatened human health. Esophageal cancer ranks 6th among the causes of cancer‐related death worldwide,[^1^](#cas14511-bib-0001){ref-type="ref"} and its 5‐year overall survival is only 20%‐40%.[^2^](#cas14511-bib-0002){ref-type="ref"} With the development of early diagnosis, radical operation, and postoperative adjuvant therapy in recent years, the prognosis for EC patients is partially improved, and the 5‐year survival rate for early EC is as high as 86%.[^3^](#cas14511-bib-0003){ref-type="ref"} The high mortality rate of EC is related to distant organ recurrence and metastasis progression. Therefore, it is urgent to investigate EC and its metastatic pathogenesis at the molecular level, and to propose the prediction and intervention strategies for EC and its metastasis.

Esophageal cancer can be mainly divided into 2 major pathological types, esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC); ESCC accounts for up to 80% of cases.[^4^](#cas14511-bib-0004){ref-type="ref"}

Circular RNAs (circRNAs) are a class of novel endogenous noncoding RNAs, which can regulate gene expression in eukaryotes. Circular RNAs can form a closed circular molecule that is free of linear RNA 5′‐ and 3′‐terminal by means of reverse splicing.[^5^](#cas14511-bib-0005){ref-type="ref"}, [^6^](#cas14511-bib-0006){ref-type="ref"} Such circular molecules are not susceptible to the RNA exonuclease, which thereby have a more stable structure than linear RNA.[^7^](#cas14511-bib-0007){ref-type="ref"} There are diverse circRNAs in mammalian cells, which are conserved.[^8^](#cas14511-bib-0008){ref-type="ref"}, [^9^](#cas14511-bib-0009){ref-type="ref"}, [^10^](#cas14511-bib-0010){ref-type="ref"} Generally, they can specifically express at the tissue development period, and exert vital roles in numerous physiological and pathological processes,[^11^](#cas14511-bib-0011){ref-type="ref"}, [^12^](#cas14511-bib-0012){ref-type="ref"} including microRNA (miRNA) sponge, regulation of gene transcription, RNA binding protein, and protein translation. The exonic circRNA can serve as the sponge to adsorb miRNAs, so as to finely regulate miRNA‐mediated gene expression.[^13^](#cas14511-bib-0013){ref-type="ref"}, [^14^](#cas14511-bib-0014){ref-type="ref"}, [^15^](#cas14511-bib-0015){ref-type="ref"} Increasing studies have verified that circRNAs play key roles as tumor suppressor genes or oncogenes in the genesis and development of various cancers, including EC proliferation and progression.[^16^](#cas14511-bib-0016){ref-type="ref"} Nonetheless, the circRNA expression profiles, function and regulation in ECs remain to be further investigated.

In this study, the differential expression of circRNAs in 10 EC tissues and paracarcinoma tissues was analyzed through circRNA microarray; in addition, the screened circRNAs were further verified in EC tissues using the quantitative RT‐PCR (qRT‐PCR) technique, so as to identify the novel circRNA, circLPAR3. Circular RNA LPAR3 showed apparently high expression in EC tissues and cells; in addition, circLPAR3 expression in EC tissues was positively correlated with clinical stage and lymph node metastasis (LNM). In in vitro experiments, circLPAR3 promoted EC cell migration and invasion, and it enhanced the lung metastasis of EC cells in in vivo experiments. Mechanically, circLPAR3 served as the sponge to adsorb miR‐198 and upregulate MET, so as to form the circLPAR3‐miR‐198‐MET signal axis, which further promoted EC cell migration. Consequently, circLPAR3 might be an important factor of EC development and metastasis.

2. MATERIALS AND METHODS {#cas14511-sec-0002}
========================

2.1. Esophageal squamous cell carcinoma patient samples {#cas14511-sec-0003}
-------------------------------------------------------

The fresh frozen ESCC tissues and corresponding paracarcinoma tissues were derived from 52 patients undergoing radical resection of EC at the Affiliated People's Hospital of Jiangsu University. All patients were naive to radiotherapy or chemotherapy before surgery. All specimens were immediately preserved in liquid nitrogen after surgery. Each patient had complete clinical and pathological data. This study was approved by the Ethics Committee of the Affiliated People's Hospital of Jiangsu University, and all patients had signed the informed consent before the study.

2.2. Cell culture {#cas14511-sec-0004}
-----------------

The ESCC cell lines ECA109, TE‐13, Kyse150, Kyse450, and Kyse510, as well as the normal esophageal epithelial HET‐1A cells, were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences. Afterwards, all cells were cultured in RPMI‐1640 culture medium supplemented with 1% streptomycin, 1% penicillin, and 10% FBS, and incubated at 37°C in 5% CO~2~ conditions.

2.3. Circular RNA microarray analysis {#cas14511-sec-0005}
-------------------------------------

Total RNA was extracted from 10 pairs of ESCC samples, and linear RNA was removed through RNase R (Epicenter) digestion. Thereafter, the enriched circRNA was amplified and transcribed into fluorescent cRNAs, followed by analysis using the Arraystar Human circRNA Array (8 × 15K; Arraystar). The microarray was scanned by the Agilent scanner G2505C, the collected images were analyzed through the Agilent feature extraction software (11.0.0.1 version), and the obtained data were analyzed.

2.4. RNA extraction and quantitative real‐time PCR {#cas14511-sec-0006}
--------------------------------------------------

The intracellular total RNA was extracted using TRIzol reagent (Invitrogen), and the tissue sample total RNA was extracted using the GeneJET RNA Purification Kit (Invitrogen) in accordance with the reagent instructions. The RT SuperMix reverse transcription kit (Vazyme Biotech) was used to reverse transcribe RNA into cDNA, and the SYBR Premix Ex Taq II (Vazyme Biotech) was used for qRT‐PCR. The relative gene expression level was calculated according to the 2^−ΔΔCT^ method, GAPDH was used to normalize the relative expression levels of circRNA and linear mRNA, whereas U6 was utilized to normalize the miRNA expression level. All primers and the related sequences used in the experiment are listed in Table [1](#cas14511-tbl-0001){ref-type="table"}.

###### 

Primer sequences used in this study

  Primer name     Sequence (5′‐3′)
  --------------- --------------------------------
  circLPAR3 For   GAGTTACCTTGTTTTCTGGACA
  circLPAR3 Res   TGGAGAAGTGAACATCCTAAG
  Met For         CACTTCTGAGAAATTCATCAGGCTGTGAAG
  Met Res         ATCTGTCAATCCTGTCCGTGT
  18S For         GGAGTATGGTTGCAAAGCTGA
  18S Res         TCCTGCTTTGGGGTTCGATT
  U6 For          CTCGCTTCGGCAGCACA
  U6 Res          AACGCTTCACGAATTTGCGT
  GAPDH For       GGGAAGCTCACTGGCATGGCCTTCC
  GAPDH Res       CATGTGGGCCATGAGGTCCACCAC
  LPAR3 For       GGGTCCATAGCAACCTGACC
  LPAR3 Res       GGGAAGAGCAGGCAGAGATG

Abbreviations: For, forward; Res, reverse.

John Wiley & Sons, Ltd

2.5. Small interfering RNA, miRNA, shRNA, and plasmid construction {#cas14511-sec-0007}
------------------------------------------------------------------

The plasmid with high LPAR3 expression, high circLPAR3expression, and the siRNAs targeting circLPAR3 were designed and synthesized by RiboBio (Guangzhou, China). In addition, shRNA targeting circLPAR3 was designed based on the siRNA sequence, which was then cloned into the pGLV3/H1/GFP/Puro vector (GenePharma). MicroRNA‐198 mimic, miR‐198 inhibitor, and the corresponding control sequences were designed and synthesized by GenePharma. The si‐circLPAR3, miR‐198 mimic/negative control (NC), and miR‐198inhibitor/NC sequences used in experiment were shown in Table [2](#cas14511-tbl-0002){ref-type="table"}.

###### 

Circular RNA LPAR3 siRNA (si‐circLPAR3), microRNA (miR)‐198 mimic/negative control (NC), and miR‐198 inhibitor/NC sequences used in this experiment

  Name                         Sequence (5′‐3′)
  ---------------------------- ------------------------
  si‐circLPAR3\#1              CTAGGTTTGAAAGACTAAT
  si‐circLPAR3\#2              AGGTTTGAAAGACTAATAG
  si‐circLPAR3\#3              TGAAAGACTAATAGGGATG
  miR‐198 mimic sense          GGUCCAGAGGGGAGAUAGGUUC
  miR‐198 mimic antisense      ACCUAUCUCCCCUCUGGACCUU
  miR‐198 mimic‐NC sense       UUCUCCGAACGUGUCACGUTT
  miR‐198 mimic‐NC antisense   ACGUGACACGUUCGGAGAATT
  miR‐198 inhibitor            GAACCUAUCUCCCCUCUGGACC
  miR‐198 inhibitor‐NC         CAGUACUUUUGUGUAGUACAA

John Wiley & Sons, Ltd

2.6. Cell Counting Kit‐8 assay {#cas14511-sec-0008}
------------------------------

Esophageal squamous cell carcinoma cell proliferation was detected according to the CCK‐8 assay. In brief, 2000 ESCC cells were inoculated into the 96‐well plate, and 10 µL CCK‐8 solution was added into each well after 24, 48, 72, and 96 hours of transfection (Dojindo) to culture for 2 hours at 37°C. The absorbance value was measured at the wavelength of 450 nm.

2.7. Colony formation assay {#cas14511-sec-0009}
---------------------------

Five hundred Kyse450 cells were inoculated into each well of 6‐well plates and cultured continuously for 14 days. Thereafter, cells were fixed with methanol for 1 hour, and the colonies formed were counted at 1 hour after crystal violet staining.

2.8. Transwell assays {#cas14511-sec-0010}
---------------------

After 48 hours of cell transfection, 100 μL serum‐free culture solution containing 2 × 10^4^ ESCC cells was added into the upper Transwell chamber (8‐μm pore size). In the invasion assay, the upper chamber was coated with Matrigel (BD Biosciences), while 600 μL culture solution was added to the lower chamber containing 10% FBS. Later, the TE13 cells were cultured for 12 hours, and the Kyse450 cells were cultured for 24 hours. Cells that penetrated the chamber diaphragm were fixed with methanol for 1 hour and stained with crystal violet (Beyotime Biotechnology) for 30 minutes. All cells were then magnified under a microscope at 200× magnification, and 5 fields of view were randomly selected for observation and counting.

2.9. RNase R treatment assay {#cas14511-sec-0011}
----------------------------

Six units of RNase R (Geneseed Biotech) were added into every 2 µg RNA and incubated at 37°C for 20 minutes. After RNase R treatment, the mRNA expression of circLPAR3 and LPAR3 was detected by qRT‐PCR.

2.10. RNA FISH {#cas14511-sec-0012}
--------------

The cy3‐labeled circLPAR3 probe was purchased from RiboBio. Then the probe signal was detected using the FISH kit (RiboBio) according to the manufacturer's instructions. Zeiss AIM software and the Zeiss LSM 700 confocal microscope system (Carl Zeiss) were used to capture the confocal images of cells.

2.11. RNA nuclear‐cytoplasmic separation experiment {#cas14511-sec-0013}
---------------------------------------------------

The nuclear and cytoplasmic RNA was extracted using the PARIS kit (Invitrogen) in accordance with the manufacturer's instructions. The relative expression quantities of circLPAR3 in the cell nucleus and cytoplasm were detected by qRT‐PCR.

2.12. RNA immunoprecipitation assay {#cas14511-sec-0014}
-----------------------------------

The EZMagna RIP kit (Merck) was utilized to accomplish the RNA immunoprecipitation (RIP) assay. In brief, the RIP lysis buffer was used in ESCC cell lysis, and the lysate was incubated for 6 hours with the magnetic beads previously binding to anti‐Argonaute 2 (AGO2) (Abcam) or anti‐IgG Ab. Afterwards, the magnetic beads were cleaned and digested with proteinase K to remove the protein. Finally, the purified RNA was analyzed through qRT‐PCR.

2.13. Dual‐luciferase reporter gene assay {#cas14511-sec-0015}
-----------------------------------------

Circular RNA LPAR3‐wt or circ0006168‐mut was constructed into the dual‐luciferase reporter vector (GP‐miRGLO). Kyse450 cells were cultured for 24 hours in a 24‐well plate at the density of 5 × 10^4^ cells/well for transfection. Lipofectamine 2000 (Invitrogen) was used to cotransfect the dual‐luciferase reporter gene plasmid and miR‐198 mimics or miR‐198 mimic‐NC into Kyse450 cells. Forty‐eight hours later, the luciferase activities were measured using the dual‐luciferase reporter detection kit (Promega).

2.14. Western blot analysis {#cas14511-sec-0016}
---------------------------

Cells were cultured for 48 hours after cell transfection, the protein was extracted using the RIPA lysis buffer (Thermo Fisher Scientific), and quantified using the BCA kit (Beyotime Biotechnology). Sample (30 µg) was collected, separated through 10% PAGE, and electronically transferred onto the PVDF membranes. Then the membranes were blocked with blocking solution at 37°C for 1 hour under gentle shaking in the shaking table. Thereafter, primary Abs were added to incubate at 4°C overnight and secondary Ab was added to incubate at 37°C for 1 hour. Chemiluminiscence was detected by the enhanced chemiluminescence system (Yeasen), then processed and analyzed by the gel imaging system. Tubulin was used as the internal reference protein. The experiment was repeated 3 times. The Abs used in this experiment were as follows: MET (1:2000; Abcam); P‐Akt (1:2000; Proteintech); P‐MAPK (1:2000; Cell Signaling Technology), Tubulin (1:1000; Beyotime Biotechnology), and HRP‐conjugated secondary Ab (1:1000; Beyotime Biotechnology).

2.15. Animal studies {#cas14511-sec-0017}
--------------------

All animal experiments were proved by the Institutional Animal Care and Use Committee of Nanjing Medical University. Each 5‐week‐old BALB/c nude mouse was injected with 100 μL TE13 cells with stably low circLPAR3\#3 expression (shcircLPAR3\#3) or control cells (shRNA control) through the caudal vein at the cell density of 1 × 10^7^ cells/mL. Mice were killed at the 6th week after caudal vein injection, the lung tissues were dissected and photographed, the lung tissue pathological sections were used for H&E staining and immunohistochemical (IHC) examination, and the number of lung tumor metastasis was counted.

2.16. Statistical analysis {#cas14511-sec-0018}
--------------------------

The SPSS 22.0 (IBM) statistical analysis software was adopted for data analysis. All experimental data were expressed as mean ± SD. Pairwise comparison between 2 groups was carried out by *t* test, and the correlations of circLPAR3 expression with clinical parameter characteristics were analyzed by Pearson's χ^2^ test. A difference of *P* \< .05 was deemed as statistically significant.

3. RESULTS {#cas14511-sec-0019}
==========

3.1. Circular RNA LPAR3 expression level increased in human ESCC tissues and cell lines {#cas14511-sec-0020}
---------------------------------------------------------------------------------------

To investigate circRNAs expression in EC tissues, the 10 pairs of EC and paracarcinoma tissues were carried out circRNA microarray analysis, and the circRNA expression patterns were displayed through hierarchical clustering between ESCC tissues and paracarcinoma tissues (Figure [1A](#cas14511-fig-0001){ref-type="fig"}). Changes in the circRNA expression were discovered in the volcano (Figure [1B](#cas14511-fig-0001){ref-type="fig"}) and scatter (Figure [1C](#cas14511-fig-0001){ref-type="fig"}) plots. Microarray results suggested that, compared with paracarcinoma tissues, circCNOT6L had the most obvious elevation, followed by circLPAR3; in addition, the top 10 candidate circRNAs in terms of fold upregulation were selected from the detection results for further analysis (Table [3](#cas14511-tbl-0003){ref-type="table"}). Subsequently, they were verified in the 10 pairs of ESCC and paracarcinoma tissues through qRT‐PCR. As was observed, these 10 candidate circRNAs were upregulated, which was consistent with the microarray results, but circLPAR3 had the highest fold of differential expression (Figure [1D](#cas14511-fig-0001){ref-type="fig"}). As a result, *circLPAR3* was selected as the target gene for investigation. Then circLPAR3 was detected in various ESCC cell lines, as well as in the 52 pairs of EC and paracarcinoma tissues through qRT‐PCR, and the results suggested that circLPAR3 expression was apparently upregulated in ESCC tissues and cell lines (Figure [1E,F](#cas14511-fig-0001){ref-type="fig"}). Expression of circLPAR3 in ESCC tissues was markedly higher than that in paracarcinoma tissues; in addition, the high circLPAR3 expression was correlated with LNM and advanced TNM stage, but not with age, sex, tumor infiltration depth, or tissue differentiation degree (Table [4](#cas14511-tbl-0004){ref-type="table"}). These experimental data revealed that circLPAR3 promoted the invasion and metastasis of ESCC.

![Screening of target gene circular RNA LPAR3 (circLPAR3) as the biomarker of esophageal squamous cell carcinoma (ESCC) invasion and metastasis. A, The high‐throughput sequencing results of 10 pairs of ESCC and paracarcinoma tissues, the differential expression of circRNA in ESCC and paracarcinoma tissues is analyzed through heat map and hierarchical clustering analysis, and the relative expression levels of circRNA were arranged from the highest to the lowest levels, as denoted in red and green, respectively. B, The *X* axis in the volcano plot represents the fold change (FC); the *Y* axis indicates the *P* value. The *P* value at the green boundary = .05, FC = 2.0, and the red points in the plot represent the differentially expressed circRNAs. C, Scatter plot is drawn to learn the expression data distribution in the microchip, and a greater data scattering degree indicates a greater difference degree. *X* and *Y* axes indicate the signal values after standardization, in which the green line stands for the FC. In this experiment, the differential expression standards are set at FC ≥ 2.0 or ≤0.5, which refer to the region above the upper green line and the region below the lower green line in the plot, respectively. D, CircLPAR3 expression in 10 pairs of ESCC and paracarcinoma tissues verified by qRT‐PCR. E, CircLPAR3 expression in 52 pairs of ESCC tissues and matched paracarcinoma tissues detected by quantitative RT‐PCR. F, CircLPAR3 expression in ESCC‐related cell lines. \*\**P* \< .01, \*\*\**P* \< .001](CAS-111-2824-g001){#cas14511-fig-0001}

###### 

Top 10 upregulated circular RNAs (circRNAs) detected by circRNA microarray sequencing

  circRNA       Regulation   FC     *P*‐value   Chrom   circRNA type
  ------------- ------------ ------ ----------- ------- --------------
  circCNOT6L    Up           18.1   .002        chr4    Exonic
  circLPAR3     Up           10.4   .004        chr1    Exonic
  circKRT14     Up           9.3    .000        chr17   Exonic
  circKRT7      Up           7.7    .004        chr12   Exonic
  circZFR       Up           7.4    .000        chr5    Exonic
  circHMGA2     Up           6.8    .001        chr12   Exonic
  circKRT5      Up           6.5    .005        chr12   Exonic
  circRAPGEF5   Up           6.3    .021        chr7    Exonic
  circFIG4      Up           6.0    .000        chr6    Exonic
  circPRRC2B    Up           5.8    .000        chr9    Intronic

Abbreviations: Chrom, chromosome; FC, fold change.

John Wiley & Sons, Ltd

###### 

Relationship between circular RNA LPAR3 (circLPAR3) expression and clinicopathologic features of esophageal squamous cell carcinoma

  Characteristic             All patients   CircLPAR3 low expression   CircLPAR3 high expression   *P* value
  -------------------------- -------------- -------------------------- --------------------------- ------------------------------------------------
  N                          52             26                         26                          
  Age (y)                                                                                          
  \<60                       4              1                          3                           .611
  ≥60                        48             24                         24                          
  Gender                                                                                           
  Male                       40             22                         18                          .188
  Female                     12             4                          8                           
  Histological grade                                                                               
  Moderate                   38             17                         21                          .427
  Poor                       14             8                          6                           
  Tumor infiltration depth                                                                         
  T1‐T2                      30             18                         12                          .092
  T3‐T4                      22             8                          14                          
  TNM stage                                                                                        
  I‐II                       26             19                         7                           .001[\*\*](#cas14511-note-0004){ref-type="fn"}
  III‐IV                     26             7                          19                          
  Lymph metastasis                                                                                 
  Yes                        26             7                          19                          .001[\*\*](#cas14511-note-0004){ref-type="fn"}
  No                         26             19                         7                           

*P* \< .01.

John Wiley & Sons, Ltd

3.2. Biological characteristics of circLPAR3 in ESCC {#cas14511-sec-0021}
----------------------------------------------------

According to the circBase database, circLPAR3 was derived from the linear gene *LPAR3* located on chromosome 1, which was formed through the single cyclization of exon 2 on LPAR3 mRNA and was 754 bases in length (Figure [2A](#cas14511-fig-0002){ref-type="fig"}). To investigate its characteristics in ESCC, we had designed the circLPAR3 back‐to‐back primers for gene amplification and base sequencing, and our results confirmed the presence of a shearpoint sequence of reverse splicing of exon 2 in the circLPAR3 sequence (Figure [2B](#cas14511-fig-0002){ref-type="fig"}). Afterwards, total RNA was extracted from the ESCC Kyse450 cells, and the 3′‐5′ exoribonuclease‐RNase R was added for digestion. The processed RNA was detected through qRT‐PCR after reverse transcription, which suggested that the linear LPAR3 mRNA was apparently degraded, but it made no distinct difference to the expression of the closed circular circLPAR3 (Figure [2C](#cas14511-fig-0002){ref-type="fig"}). The above results confirmed that circLPAR3 had superior stability in ESCC cells to its linear LPAR3 mRNA. The FISH assay and RNA nuclear‐cytoplasmic separation results revealed that circLPAR3 was mainly distributed in the cytoplasm of ESCC cells, while a small portion was located in the nucleus (Figure [2D,E](#cas14511-fig-0002){ref-type="fig"}). The above experiments verified that circLPAR3 was an exonic circular RNA that was mainly located in the cytoplasm of ESCC cells.

![Biological characteristics of circular RNA LPAR3 (circLPAR3) in esophageal squamous cell carcinoma cells. A, CircLPAR3 origin, composition, and length. B, Sanger sequencing results of circLPAR3, in which the black arrow indicates the cyclization site. C, CircLPAR3 and linear LPAR3 mRNA expression in Kyse450 cells before and after RNase R treatment detected by quantitative RT‐PCR. D, E, RNA nuclear‐cytoplasmic separation (D) and FISH (E) experiments to understand circLPAR3 distribution in Kyse450 cells, with U6 and 18S rRNA as the positive controls of nuclear component and cytoplasmic component, respectively (scale bar = 20 µm). \*\*\**P* \< .001](CAS-111-2824-g002){#cas14511-fig-0002}

3.3. Circular RNA LPAR3 promoted migration and invasion of ESCC cell lines in vitro {#cas14511-sec-0022}
-----------------------------------------------------------------------------------

Three siRNAs were designed at the reverse connection site formed by circLPAR3, and qRT‐PCR detection was carried out after transfection of ESCC cells. These 3 siRNAs specifically knocked out circLPAR3 expression, among which, si‐circLPAR3\#2 and si‐circLPAR3\#3 had better knockout effect, without affecting the expression of its linear gene *LPAR3* (Figure [3A‐C](#cas14511-fig-0003){ref-type="fig"}). After circLPAR3 KO in Kyse450 cells, Transwell assay results indicated that the cell migration and invasion capacities were apparently suppressed (Figure [3D](#cas14511-fig-0003){ref-type="fig"}). Transfection of high circLPAR3 expression plasmid in Kyse450 cells markedly upregulated the circLPAR3 expression level, but it did not affect the expression level of its linear gene *LPAR3* (Figure [3E](#cas14511-fig-0003){ref-type="fig"}‐G). Transfection of LPAR3 overexpression plasmid into TE‐13 cells not only successfully increased the expression of linear LPAR3, but also increased circLPAR3 expression in TE‐13 cells (Figure [3H,I](#cas14511-fig-0003){ref-type="fig"}). Similarly, the Transwell assay showed that high circLPAR3 expression promoted the migration and invasion capacities of ESCC cells (Figure [3J](#cas14511-fig-0003){ref-type="fig"}). Additionally, cell colony formation and CCK‐8 assays were carried out to detect the effect of low circLPAR3 expression in Kyse450 cells on cell proliferation, and our results revealed no obvious difference in cell proliferation between low circLPAR3 expression group and control group (Figure [3K](#cas14511-fig-0003){ref-type="fig"},L).

![Circular RNA LPAR3 (circLPAR3) promotes esophageal squamous cell carcinoma cell migration and invasion in vitro. A, CircLPAR3 expression levels in si‐circLPAR3‐transfected Kyse450 cells detected by quantitative (q)RT‐PCR. B, C, CircLPAR3 and LPAR3 expression levels in si‐circLPAR3‐transfected TE13 cells detected by qRT‐PCR. D, Changes in Kyse450 cell migration and invasion capacities after downregulating circLPAR3 expression detected by Transwell assay. E, CircLPAR3 expression levels in TE13 cells transfected with high circLPAR3 expression plasmid detected by qRT‐PCR. F, G, CircLPAR3 and LPAR3 expression levels in Kyse450 cells transfected with high circLPAR3 expression plasmid detected by qRT‐PCR. H, I, Expression of LPAR3 and circLPAR3 in TE13 cells after LPAR3 overexpression plasmid transfection was determined by qRT‐PCR. J, Effect of high circLPAR3 expression on TE13 cell migration and invasion capacities detected by Transwell assay. K, Proliferation of Kyse450 cells after circLPAR3 knockout for 24, 48, 72, and 96 h detected by CCK‐8 assay. L, Kyse450 cell proliferation after circLPAR3 KO detected in cell colony formation assay. \*\**P* \< .01, \*\*\**P* \< .001](CAS-111-2824-g003){#cas14511-fig-0003}

3.4. Circular RNA LPAR3 served as miRNA sponge for miR‐198 in ESCC cells {#cas14511-sec-0023}
------------------------------------------------------------------------

Our research results suggested that circLPAR3 promoted ESCC cell migration and invasion, but the precise molecular mechanism remains unclear. Using Arraystar's home‐made software, it was predicted that 5 miRNAs had the binding sites with circLPAR3, including miR‐198, miR‐2682‐5p, miR‐4692, miR‐6511a‐5p, and miR‐6780‐5p. Moreover, the seed sequence located in the 5′‐terminal of miRNA (No.2‐7nt) forms the Watson‐Crick pair with target gene 3′UTR, which is the most important factor in the prediction of all miRNA target genes. The specificity efficiency is shown below: 8mer \> 7mer‐m8 \> 7merA1 \> 6mer. Typically, the binding site of circLPAR3 with miR‐198 belonged to the 8mer site type (Figure [4A](#cas14511-fig-0004){ref-type="fig"}), which had higher specificity than other miRNA bindings. Additionally, numerous studies had reported the close relationship of miR‐198 with tumor, whereas the association of the remaining 4 miRNAs with tumor had not been reported. Therefore, miR‐198 was selected as the preferred object of study. The downstream target gene of miR‐198 was predicted based on databases PicTar, miRTarBase, TargetScan, and miRBase, and the intersection of these 4 databases was obtained to acquire a target gene, *MET* (Figure [4B](#cas14511-fig-0004){ref-type="fig"}); additionally, the binding site of the circLPAR3‐miR‐198‐MET seed sequence was predicted using TargetScan software (Figure [4C](#cas14511-fig-0004){ref-type="fig"}). Based on the binding site of circLPAR3 with miR‐198, the circLPAR3 WT and mutant dual‐luciferase reporter gene plasmids were designed and synthesized (Figure [4D](#cas14511-fig-0004){ref-type="fig"}), and the circLPAR3 WT or mutant plasmids were cotransfected into TE13 cells with miR‐198 mimics or miR‐198 mimic‐NC. The results suggested that, miR‐198 only reduced the luciferase activity of circLPAR3 WT plasmid, but it had no influence on the luciferase activity of the circLPAR3 mutant plasmid (Figure [4E](#cas14511-fig-0004){ref-type="fig"}). In Kyse450 and TE13 cells, RIP experimental results revealed that, compared with IgG group, miR‐198 and circLPAR3 expression levels in the Ago2 group were notably higher than those in the control group (Figure [4F](#cas14511-fig-0004){ref-type="fig"},G). The above experiments verified that circLPAR3 served as a sponge of miR‐198 in ESCC cells.

![Circular RNA LPAR3 (circLPAR3) serves as a sponge of microRNA (miR)‐198. A, Schematic diagram predicting the potential binding sites of circLPAR3 with miR‐198. B, Venn diagram suggests the common downstream target genes of miR‐198 predicted in 4 databases (PicTar, miRTarBase, TargetScan, and miRBase). C, Schematic diagram presenting the binding sites of circLPAR3‐miR‐198‐MET. D, Dual‐luciferase reporter gene plasmid mutation sites of circLPAR3. E, Luciferase activities detected after cotransfection of WT circLPAR3 or mutant circLPAR3 with miR‐198 mimics or miR‐198 mimic‐negative control (NC) detected through dual‐luciferase reporter gene assay. F, G, Binding of circLPAR3 and miR‐198 with AGO2 protein in Kyse450 and TE13 cells detected through RIP assay. \*\**P* \< .01, \*\*\**P* \< .001](CAS-111-2824-g004){#cas14511-fig-0004}

3.5. Circular RNA LPAR3 targeted *MET* through sponge adsorption of miR‐198 {#cas14511-sec-0024}
---------------------------------------------------------------------------

Quantitative RT‐PCR and western blotting experimental results revealed that overexpression of miR‐198 in TE13 cells apparently downregulated MET mRNA and the coded c‐MET protein levels, whereas miR‐198 KO in TE13 cells markedly upregulated MET mRNA and c‐MET protein levels (Figure [5A‐D](#cas14511-fig-0005){ref-type="fig"}), suggesting that *MET* was the direct target gene of miR‐198. High circLPAR3 expression remarkably increased the c‐MET protein expression (Figure [5E](#cas14511-fig-0005){ref-type="fig"}), whereas low circLPAR3 expression dramatically decreased c‐MET protein level, as well as the phosphorylation levels of its downstream proteins MAPK and AKT (Figure [5F](#cas14511-fig-0005){ref-type="fig"}). Transwell assay indicated that overexpression of miR‐198 reversed the promoting effect of high circLPAR3 expression on ESCC cell migration (Figure [5G](#cas14511-fig-0005){ref-type="fig"}). Western blotting results indicated that overexpression of miR‐198 reversed the upregulation of high circLPAR3 expression on c‐MET level as well as the phosphorylation levels of its downstream proteins MAPK and AKT (Figure [5H](#cas14511-fig-0005){ref-type="fig"}). The above experimental results showed that circLPAR3 adsorbed miR‐198 to upregulate MET expression and promote ESCC cell migration.

![Circular RNA LPAR3 (circLPAR3) adsorbs microRNA (miR)‐198 and targets MET to promote esophageal squamous cell carcinoma (ESCC) cell migration. A‐D, Effects of downregulating and upregulating miR‐198 expression on the *MET* gene and c‐MET protein detected through quantitative RT‐PCR and western blotting. E, Regulation of high circLPAR3 expression on c‐MET protein level detected through western blotting. F, Regulation of low circLPAR3 expression on c‐MET protein level and the phosphorylation levels of its downstream regulated proteins detected through western blotting. G, Transwell assay shows that overexpression of miR‐198 can reverse the promoting effect of high circLPAR3 expression on ESCC cell migration. H, Regulation of miR‐198 overexpression on the c‐MET protein level and the phosphorylation levels of its downstream regulated proteins induced from the high circLPAR3 expression, as detected through western blotting. \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001](CAS-111-2824-g005){#cas14511-fig-0005}

3.6. CircLPAR3 promoted ESCC lung metastasis {#cas14511-sec-0025}
--------------------------------------------

The abovementioned experiments were the in vitro models at cell level. To more potently verify the effect of circLPAR3 on ESCC metastasis and its molecular mechanism, we designed the in vivo model of passive ESCC metastasis. Transfection with sh‐circLPAR\#3 in TE13 cells markedly downregulated the circLPAR3 expression level (Figure [6A](#cas14511-fig-0006){ref-type="fig"}). TE13 cells with stably low circLPAR3 expression (shcircLPAR3\#3) and control cells (shRNA control) were injected into 6‐week‐old nude mice through the caudal vein at the dose of 1 × 10^6^ cells/100 μL. Mice were killed at 6 weeks after caudal vein injection, and the number of tumor nodules seen on the lung surface of the low circLPAR3 group was apparently less than those in the control group (Figure [6B](#cas14511-fig-0006){ref-type="fig"}). The H&E staining results of nude mouse lung tissue pathological sections indicated that the size and number of lung metastases in nude mice of low circLPAR3 group were apparently less than those in control group (Figure [6C,D](#cas14511-fig-0006){ref-type="fig"}). Additionally, IHC and qRT‐PCR results suggested that the c‐MET and MET expression in lung metastases of nude mice with low circLPAR3 expression was also apparently lower than that in control group (Figure [6E,F](#cas14511-fig-0006){ref-type="fig"}).

![Circular RNA LPAR3 (circLPAR3) promotes esophageal squamous cell carcinoma lung metastasis in vivo. A, CircLPAR3 expression levels in sh‐circLPAR3‐transfected TE13 cells detected by quantitative (q)RT‐PCR. B, Representative images of the tumor nodules could be seen on the lung surface in 2 groups of mice 6 wk after the tail vein injection of TE13 cells. C, Representative images of the H&E staining results of lung metastasis pathological sections in both groups (scale bars: upper, 1000 µm; lower, 100 µm). D, Quantitative analysis on the number of lung metastases in mice of both groups. E, Representative images of immunohistochemical results of lung metastases in both groups (scale bars: upper, 1000 µm; lower, 100 µm). F, Changes in circLPAR3 and MET expression in lung metastases of both groups detected through qRT‐PCR. \*\*\**P* \< .001](CAS-111-2824-g006){#cas14511-fig-0006}

4. DISCUSSION {#cas14511-sec-0026}
=============

In recent years, circRNAs have become the disease‐related research hotspot second to miRNA and long noncoding RNA. More and more studies are carried out to examine the roles of circRNAs in tumor, including EC.[^17^](#cas14511-bib-0017){ref-type="ref"} However, few studies focus on the expression and function of circRNAs in EC. In this study, high throughput sequencing was applied to screen the differentially expressed circRNAs in the 10 pairs of EC samples, and a novel circRNA (circLPAR3) with markedly elevated expression in tumor tissues was identified.

We discovered that circLPAR3 expression in EC tissues was apparently higher than that in paracarcinoma tissues, which was closely correlated with the pathological grade and LNM of EC patients. However, circLPAR3 expression was not obviously correlated with tumor infiltration depth, which might be related to the small number of ESCC patients in this study. We further confirmed that the expression of circLPAR3 were increased in ESCC cells. The LPAR3 overexpression plasmid could not only successfully increase the expression of linear LPAR3, but also increase circLPAR3 expression in ESCC cells, indicating that the elevated expression of circLPAR3 in ESCC tissues and cells was probably due to the increased expression of linear LPAR3. Moreover, in vitro and in vivo studies suggested that circLPAR3 promoted ESCC cell migration, invasion, and metastasis, but did not affect cell proliferation. Mechanically, circLPAR3 served as a sponge of miR‐198 to upregulate the MET expression level, thus promoting EC cell metastasis. To the best of our knowledge, this study is the first to report the role of circLPAR3 in ESCC.

Circular RNA is more stable than linear RNA, besides, it is enriched in cells, plasma, and even the circulatory exosome. Therefore, it can serve as the tumor diagnostic and therapeutic biomarker.[^18^](#cas14511-bib-0018){ref-type="ref"}, [^19^](#cas14511-bib-0019){ref-type="ref"} In our experiment, RNase R was adopted for cell treatment, which verified that circLPAR3 was more stable than the linear gene *LPAR3*. Combined with the previous study conclusions, high circLPAR3 expression is a high‐risk factor of EC metastasis, but it remains to be further explored and investigated whether circLPAR3 detected in blood can serve as a biomarker of EC metastasis and prognosis.

Circular RNAs can be classified as exon circRNAs, intron circRNAs, exon‐intron circRNAs (EIci RNAs) and intergenic circRNAs.[^20^](#cas14511-bib-0020){ref-type="ref"} Of them, exon circRNAs are mainly located in cytoplasm, which are the richest circRNAs in the body.[^21^](#cas14511-bib-0021){ref-type="ref"} Recent studies suggest that circRNA molecules are rich in miRNA response elements, which can competitively bind to miRNA, play a role as a miRNA sponge in cells, relieve the suppression of miRNA on its target gene, and upregulate the expression of target genes.[^15^](#cas14511-bib-0015){ref-type="ref"}, [^22^](#cas14511-bib-0022){ref-type="ref"} In this study, FISH and nuclear‐cytoplasmic separation experiments verified that circLPAR3 was mainly located in the cytoplasm, which was able to regulate miRNAs at the posttranscription level. Circular RNA LPAR3 was verified in this study to serve as a sponge of miR‐198 through bioinformatic analysis prediction, RIP, and luciferase assay.

MicroRNA‐198 can regulate cell proliferation, migration, invasion, and apoptosis in pancreatic cancer and colon cancer, thus suppressing tumor development.[^23^](#cas14511-bib-0023){ref-type="ref"}, [^24^](#cas14511-bib-0024){ref-type="ref"}, [^25^](#cas14511-bib-0025){ref-type="ref"}, [^26^](#cas14511-bib-0026){ref-type="ref"}, [^27^](#cas14511-bib-0027){ref-type="ref"} Tan et al verified that miR‐198 was able to bind with and negatively regulate c‐MET.[^28^](#cas14511-bib-0028){ref-type="ref"} c‐MET kinase is a type of transmembrane receptor with automatic phosphorylation activity encoded by the oncogene *MET*, which is expressed in both normal cells and tumor cells.[^29^](#cas14511-bib-0029){ref-type="ref"} The persistent activation of c‐MET is an important cause of tissue and cell carcinogenesis or enhanced cancer cell proliferation. c‐MET is subjected to self‐phosphorylation after it is activated, which can thereby activate the signaling pathways such as RAS/MAPK, PI3K/Akt, and STAT3/JNK, thus promoting tumor cell survival, proliferation, invasion, and angiogenesis.[^30^](#cas14511-bib-0030){ref-type="ref"}, [^31^](#cas14511-bib-0031){ref-type="ref"}, [^32^](#cas14511-bib-0032){ref-type="ref"} This study verified the mechanism of circLPAR3 in regulating c‐MET expression, which was that circLPAR3 adsorbed miR‐198 as a sponge to weaken its suppression on c‐MET expression, increase the phosphorylation of Akt and MAPK, affect the RAS/MAPK and PI3K/Akt pathways, and thus boost ESCC cell invasion and migration. We discovered in in vivo experiments that circLPAR3 KO downregulated MET expression and suppressed the lung metastasis of ESCC cells. Our study sufficiently showed that the circLPAR3‐miR‐198‐MET signal axis played a vital regulatory role in ESCC (Figure [7](#cas14511-fig-0007){ref-type="fig"}).

![Schematic diagram of the circular RNA LPAR3 (circLPAR3)‐microRNA (miR)‐198‐MET regulatory signal axis](CAS-111-2824-g007){#cas14511-fig-0007}

To sum up, the circLPAR3 expression levels in ESCC tissues and cell lines are upregulated. In ESCC, high circLPAR3 expression is positively correlated with LNM and advanced tumor TNM stage. In vivo experiment proves that low circLPAR3 expression results in a lower risk of distant metastasis. CircLPAR3 serves as a sponge of miR‐198 to regulate MET expression, thus promoting ESCC cell migration, invasion, and metastasis. The above findings support that circLPAR3 could serve as a diagnostic biomarker and therapeutic target of ESCC.
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